Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - AGILE THERAPEUTICS INC | a2231308zex-32_2.htm |
EX-32.1 - EX-32.1 - AGILE THERAPEUTICS INC | a2231308zex-32_1.htm |
EX-31.2 - EX-31.2 - AGILE THERAPEUTICS INC | a2231308zex-31_2.htm |
EX-31.1 - EX-31.1 - AGILE THERAPEUTICS INC | a2231308zex-31_1.htm |
10-K - 10-K - AGILE THERAPEUTICS INC | a2231308z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements:
- (1)
- Registration
Statement (Form S-8 No. 333-199441), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
- (2)
- Registration
Statement (Form S-3 No. 333-205120) of Agile Therapeutics, Inc. and
- (3)
- Registration Statement (Form S-8 No. 333-205116), pertaining to the Agile Therapeutics, Inc. 2014 Incentive Compensation Plan,
of our report dated March 15, 2017 with respect to the financial statements of Agile Therapeutics, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Metro
Park, New Jersey
March 15, 2017
Consent of Independent Registered Public Accounting Firm